arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

ABEONA THERAPEUTICS INC.

ABEO

$7.24 ▲ +0.35 (+5.00%) at close

17 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Bullish

auto_awesome

Analytical Summary

ABEONA THERAPEUTICS INC. shows strong fundamentals with top-quartile Return on Common Equity (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $383.4M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -49.8% ↗

FCF / Share $-1.59 ↘

Trailing P/E 5.4x

Price / Book 2.5x

FCF Yield —

Debt / Equity 0.13

info Valuation on last close. End-of-day price, Aug 7, 2026.

17-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$5.82M

↑ +66.3% —

Net Income Profit after all expenses

$71.18M

↑ +211.7% —

Operating Margin Operating profit as % of sales

-338.5%

↓ -81.7% —

FCF / Share Free cash flow per share

$-1.59

↓ -11.8% —

Long-Term Debt Long-term obligations

$20.04M

↑ +5.7% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns

Financial Health →

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Revenue Growth YoY (%)	—	—	147.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1744%)	-52.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-761%)	-70.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-975%)	—	—	258.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3127%)	-5.8% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-173%)	-14.5% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-281%)	12.4% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+55%)	-54.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-784%)	-53.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-770%)	139.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1643%)	282.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3429%)	—	—
EPS Growth YoY (%)	N/M	38.7% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	54.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	74.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	N/M	N/M	—	—	—	—
Net Income Growth YoY (%)	N/M	-17.6% Weak ↓ Weak Declining Year-over-year change in net income	-36.5% Weak ↓ Weak Declining Year-over-year change in net income	53.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-0.8% Weak ↑ Weak Improving Year-over-year change in net income	-10.4% Weak ↑ Weak Improving Year-over-year change in net income	-34.6% Weak ↑ Weak Improving Year-over-year change in net income	-107.4% Weak ↓ Weak Declining Year-over-year change in net income	-24.9% Weak ↓ Weak Declining Year-over-year change in net income	-50.6% Weak Weak Year-over-year change in net income	45.8% Excellent Excellent Year-over-year change in net income	N/M	N/M	-316.0% Weak Weak Year-over-year change in net income	66.4% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	-11.8% Weak ↓ Weak Declining Year-over-year change in free cash flow	18.5% Good ↓ Good Declining Year-over-year change in free cash flow	68.5% Excellent Excellent Year-over-year change in free cash flow	68.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	60.3% Excellent Excellent Compound annual revenue growth over 3 years	—	-29.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	—	0.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	128.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	—	42.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-3.3% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-24.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-38.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-20.5% Weak Weak Compound annual revenue growth over 3 years	61.9% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	-10.3% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	—	3.1% Caution ↓ Caution Declining Compound annual revenue growth over 5 years	11.1% Good ↓ Good Declining Compound annual revenue growth over 5 years	27.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	57.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	—	8.0% Fair ↑ Fair Improving Compound annual revenue growth over 5 years	-28.3% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-13.5% Weak Weak Compound annual revenue growth over 5 years	16.7% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	-338.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2357%)	-186.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1342%)	-98.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-753%)	-428.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2955%)	—	—
Effective Tax Rate (%) (%)	0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.7% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	-239.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2093%)	-137.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1247%)	—	—
FCF Margin (%) (%)	—	—	—	—	—	-363.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	-90.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-415.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	-1.18x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.10x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.43x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.38x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	3.02x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Return on Invested Capital (%)	-49.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-80.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-251.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-150.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-167.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-62.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-34.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-34.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-51.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	20.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	20.0% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	45.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	37.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-40.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-58.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-73.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-79.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-112.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-53.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-33.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-21.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-620.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-249.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-208.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-88.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	44.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+198%)	-144.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1065%)	—	-148.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1089%)	-200.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1436%)	-82.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-648%)	-42.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-385%)	-42.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-382%)	-16.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-207%)	-22.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-247%)	-21.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-243%)	—	-30.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-301%)	61.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+311%)	14.4% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	36.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+142%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Debt to Equity (x)	0.13x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-79%)	0.43x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-28%)	—	—	—	—	—	—	—	—	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.08x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-86%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—
Interest Coverage (x)	-23.92x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-15.26x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-112.76x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-69.18x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-24.57x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-19.79x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-5287.82x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3479.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3980.17x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3091.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-5.38x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-13.63x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.10x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.18x Weak Weak Operating income divided by interest expense Optimal: > 5x	-12.78x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-58.40M	$-4.39M	$-14.47M	$-14.22M	$-32.94M	$-12.60M	$-129.26M	$-18.75M	$-137.75M	$-69.14M	$-40.14M	$-11.12M	$-424.00K	$-396.00K	$-2.46M	$-7.03M	$-607.00K
Debt / EBITDA (x)	-0.23x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.30x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.13x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Revenue per Share (USD)	$0.11	—	$0.16	$0.18	$0.76	—	—	—	—	—	$0.04	$0.48	$4.04	$0.18	—	—	—
Basic EPS, GAAP (USD)	$1.34	$-1.55	$-2.53	$-5.53	$-21.57	—	—	—	—	—	—	$-15.26	$3.07	$-0.52	—	—	—
Free Cash Flow per Share (USD)	$-1.59	$-1.42	$-1.75	$-5.55	$-17.73	—	—	—	—	—	—	—	—	$-0.16	—	—	—
Book Value per Share (USD)	$2.89	$0.96	$0.56	$1.51	$7.20	$1.07	$2.13	$2.80	$3.63	$2.46	$2.45	$2.48	$-29.27	$-0.71	—	—	—
Tangible Book Value per Share (USD)	$2.89	$0.96	$0.56	$1.51	$7.20	$0.73	$1.75	$2.12	$2.94	$1.66	$1.28	$2.48	$-29.27	$-0.71	—	—	—
Basic Weighted Avg Shares (shares)	52.95M	41.05M	21.38M	7.86M	3.94M	—	—	—	—	—	27.60M	1.94M	504,863	24.18M	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Working Capital (USD)	$175.34M	$84.27M	$42.31M	$45.32M	$39.67M	$55.78M	$93.69M	$68.50M	$134.99M	$61.12M	$39.09M	$8.66M	$-8.39M	$-4.95M	$-8.88M	$-6.14M	—
LT Debt (USD)	$20.04M	$18.96M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$159.22M	$44.03M	$14.83M	$26.76M	$42.37M	$102.55M	$178.43M	$134.04M	$170.10M	$99.10M	$67.72M	$4.82M	$-14.78M	$-17.08M	$-17.61M	$-20.80M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Sales/Revenue/Turnover (USD)	$5.82M	—	$3.50M	$1.41M	$3.00M	$10.00M	—	$3.00M	$837.00K	$889.00K	$1.04M	$925.00K	$2.04M	$4.40M	$1.84M	$481.00K	—
Depreciation Expense (USD)	$2.55M	$2.00M	$2.29M	$3.09M	$3.25M	$4.59M	$7.82M	$2.36M	$741.00K	$825.00K	$551.00K	$11.00K	$3.00K	$419.00K	$233.00K	$238.00K	—
Net Income, GAAP (USD)	$71.18M	$-63.73M	$-54.19M	$-39.70M	$-84.94M	$-84.23M	$-76.28M	$-56.67M	$-27.32M	$-21.87M	$-14.53M	$-26.78M	$4.45M	$-10.53M	$-2.53M	$-7.54M	—
Operating Cash Flow (USD)	$-76.33M	$-56.02M	$-37.01M	$-43.48M	$-65.67M	$-35.02M	$-62.82M	$-39.11M	$-22.66M	$-13.01M	—	—	—	$-3.96M	$-7.61M	$-6.86M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 66 quarters

ABEONA THERAPEUTICS INC.

Analytical Summary

17-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ABEO with peers